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The antigen-induced  release of the chemical mediators, histamine and slow-reacting 
substance of anaphylaxis (SRS-A), 1 from sensitized  human lung fragments requires 
divalent cations (1)  and an intact glycolytic pathway (2), and is modulated by the 
intracellular  concentrations  of cyclic  3',5'-adenosine monophosphate  (cyclic AMP) 
(2-4). These characteristics also hold for the immunologic  release  of histamine from 
guinea pig lung  fragments  (5,  6),  human  basophils  in  a  population  of  peripheral 
leukocytes (7, 8), and rat mast cells in a peritoneal cell suspension  (9, 10). Mediator 
release from these same tissues except for the human peripheral leukocyte suspension 
depends in addition upon the activation of an esterase to a form that can be inhibited 
by diisopropylphosphofluoridate (DFP)  (2,  11,  12). 
The  antigen-induced  reaction  in  sensitized  guinea  pig  ileal  strips  or  lung 
fragments  (13,  14),  rat  peritoneal  cells  (14),  human  leukocyte  suspensions 
(15), or human lung fragments (1) has been separated into two phases: activa- 
tion by antigen challenge in the absence of calcium and release by restoration 
of the  calcium content without  the  addition  of further  antigen.  The present 
studies  reveal  five of  the  steps  interpolated  between  antigen  challenge  and 
release of histamine and  SRS-A from human lung  tissue passively sensitized 
with  human  IgE  antibodies  directed  against  ragweed  antigens:  a  calcium- 
dependent  activation of a  serine  esterase;  a  further  autocatalytic  activation 
of the esterase; an energy requirement; a second calcium-requiring, ethylenedi- 
aminetetraacetate  (EDTA)-inhibitable  stage;  and  a  cyclic  AMP-inhibitable 
phase. 
Materials and Methods 
DL-Isoproterenol hydrochloride and  2-deoxy-D-glucose  (2-DG) (Sigma Chemical Co.,  St. 
Louis, Mo.);  DFP  (Aldrich Chemical Co., Inc.,  Milwaukee, Wis.); and  disodium-, tetra- 
* Supported by grants AI-07722, RR4}5669, and AI-10356 from the National  Institutes 
of Health. 
Postdoctoral Fellow of the National Tuberculosis and Respiratory Disease Association. 
1Abbre~ations used in thls paper: 8-bromo cyclic GMP, 8-bromo cyclic 3',5'-guanosine 
monophosphate; cyclic AMP, cyclic 3',S'-adenosine monophosphate; DFP, diisopropylphos- 
phofluoridate; 2-DG, 2-deoxy-D-glucose;  pmol/mg  prot N, picomoles per milligram of pro- 
tein nitrogen; SRS-A, slow-reacting  substance of anaphylaxis. 
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sodium-, and disodium magnesium-EDTA  (Fisher Scientific Co.,  Pittsburgh, Pa.)  were ob- 
tained from the manufacturers. Antigen E  was kindly supplied by the Research Resources 
Branch, National Institutes of Health. 
Human lung tissue obtained at the time of surgery (16) was dissected free of pleura, bronchi, 
large blood vessels, and grossly diseased areas; sensitized by incubation in the serum of either 
patient E.W.  (16)  or patient S.A.G.  (4)  for  16-18 h  at room  temperature; washed free  of 
serum; and placed at 37°C,  unless otherwise stated, in 3  ml of Tyrode's buffer containing 
any agent(s) under study. The sensitized fragments were challenged with 0.2 #g/ml antigen 
E  3  rain later, unless denoted otherwise in the text; and the histamine and SRS-A released 
into the diffusate over the next 15 rain were quantitated by bioassay on the isolated, atro- 
pinized guinea pig ileum  (17).  Residual tissue histamine was extracted  by boiling the lung 
fragments for 8  min. All agents were prepared iust before use in Tyrode's buffer  modified 
with regard to glucose,  calcium, and magnesium content as specified in the text;  at the con- 
centrations studied,  these agents did not interfere with the bioassay of  histamine or SRS-A 
or induce a nonspecific release of mediators in the absence of antigen challenge. 
The  experimental  design  (Fig.  1)  for  studies  of  the  reaction sequence  depended  upon 
arresting  the  progression  of  antigen-induced  mediator  release  by  an  initial manipulation, 
washing  the  tissue,  and  determining subsequent mediator  release  in  a  buffer  that  lacked 
antigen and was corrected as regards the  initial manipulation but altered with respect to an 
additional condition or  agent.  The  inhibition of  mediator release  by  the second condition 
indicates that its site of action must follow the first. Conversely, failure of the second condi- 
tion  to  influence mediator  release  indicates  that  the  reaction has progressed  beyond  this 
step during the initial manipulation. The interpretation of either result requires full release 
of mediators after removal of the initial inhibitory condition. 
The  quantity of histamine or SRS-A released from the sensitized tissue by antigen chal- 
lenge under the usual conditions,  15 min at 37°C  in Tyrode's buffer in the absence of any 
agents, was taken as 100%; and the percent inhibition of mediator release by each manipula- 
tion and the percent reversibility of mediator release after correction of each manipulation 
(Fig.  1) was calculated on that basis. 
Cyclic AMP was quantitated by employing the cyclic AMP-binding protein assay  (18) 
as described (4). 
RESULTS 
DFP-Sensitive Serine Esterase.-- 
Generation:  Preliminary experiments (2)  that indicated  that histamine but 
not SRS-A release could be used to study an antigen-activated serine  esterase 
were  substantiated.  Treatment  of  sensitized  human  lung  fragments  with  6 
mM DFP for 1 rain before antigen challenge suppressed the release of histamine 
and SRS-A, while removal of DFP by washing before antigen challenge per- 
mitted release of mediators (Table I, exp. A). Exposure of the lung fragments 
to DFP for 3-5 rain, followed by washing, resulted in progressive impairment 
of the antigen-induced release of SRS-A but had no effect on histamine release 
(Table I,  exp. B). As DFP irreversibly phosphorylates serine residues in  the 
active center of susceptible enzymes (19), the DFP-sensitive esterase involved 
in histamine release must  be maintained  in a  DFP-resistant precursor  form 
until activated by the interaction of antigen with  tissue-fixed IgE  antibody. 
In contrast, the progressive inhibition of SRS-A release by DFP unrelated to 
antigen challenge reveals a preformed DFP-sensitive step and does not permit 
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FIG.  1.  Experimental design. Replicate 200-mg  samples of sensitized human lung tissue 
fragments were challenged with antigen (AGE) in a  buffer containing an initial inhibitory 
condition. Samples handled in parallel and washed after antigen challenge in order to remove 
both antigen and the initial inhibitory condition were resuspended in either Tyrode's buffer 
or in buffer containing a second inhibitory condition. 
TABLE  I 
Effects  of Preincubation with  DFP  on  the Immunologic  Rdease  of Mediators from  Human 
Lung Tissue 
Removal  Histamine  release  SRS-A  release  DFP  Preincubation  (3 washes) 
min  %  U/g 
Exp. A* 
6 mM  1  -- 
6 mM  1  + 
Exp. ~:~ 
5 mM  1  + 
5 mM  3  + 
5 mM  5  + 
14  500 
4  50 
10  400 
21  500 
20  560 
20  225 
19  150 
* Sensitized human lung fragments incubated in DFP for 1 min were either challenged 
with antigen in the presence of DFP or washed three times and resuspended in DFP-free 
buffer before challenge. 
Sensitized human lung fragments were incubated with DFP for 1-5 min, washed three 
times, resuspended in DFP-free buffer, and challenged with antigen. 1080  ANTIGEN-INDUCED  RELEASE  OF  CHEMICAL MEDIATORS 
only histamine release was used in further assessment of the  immunological]y 
activated DFP-sensitive  esterase. 
As the DFP-sensitive esterase involved in histamine release exists in a  DFP- 
resistant precursor form, the capacity for lung tissue challenged with  antigen 
in  the presence of DFP  to  release histamine  after washing  reflects residual 
proesterase  activatable  by  tissue-bound  antigen.  Sensitized  lung  fragments 
were treated with DFP  (5 raM),  interacted with antigen  10 s later,  and in- 
cubated  for  an  additional  1-13  rain  at  37°C.  The  antigen-challenged  lung 
fragments were removed, washed, and resuspended in Tyrode's buffer; and the 
amount of histamine released was compared with that from samples that  had 
not  been  exposed  to  DFP  (Fig.  2).  No  histamine  release  occurred  at  any 
interval in the presence of DFP. Removal of DFP 1 rain after antigen challenge 
permitted nearly full release, while release declined progressively as the interval 
between challenge and DFP removal was extended. Thus the  antigen-induced 
activation of the esterase to its DFP-sensitive form occurred continually over 
the 13 rain period such that after a 13 rain incubation of sensitized lung fragments 
with antigen in the presence of DFP, only a small portion of the esterase was 
still available in the precursor form for activation by tissue-bound  antigen. 
The experimental design used to examine the activation of the  esterase  at 
37°C was next employed at 0°C (Fig. 3). Sensitized lung  fragments  incubated 
with antigen at 0°C  for 15  and 30 min did not release histamine,  but  after 
being washed and transferred to Tyrode's buffer at 37°C yielded full histamine 
release as compared with replicates initially challenged with antigen  at  37°C. 
Tissue challenged with antigen in the presence of DFP (5 raM) at 0°C  for  15 
10 
~  s 
4 
Sensitized Lung  DFP +AgE  Tyrode's 
Frogmenls  ~  t-15rnin  "~-~W°sh''-~"  Buffer 
2L- 
0  c.- .... ~  .....  ~.-  .....  -o-  .....  -.0 
L  __  1~  __  ~_  _  J  r 
4  7  10  13 
M/NUTES  POSTANTIGEN  CH.,~LL Ef/GE 
FIG. 2.  Time course of the antigen-induced generation of the DFP-sensitive esterase at 
37°C.  (O---O), percent histamine released from sensitized lung  fragments by  antigen in 
the presence of DFP; (•--•),  percent histamine released after washing and transfer of lung 
fragments to Tyrode's buffer. Antigen-induced histamine release from replicate samples that 
had never been exposed to DFP was 12.5%. MICHAEL  KALINER  AND  K.  FRANK  AUSTEN  1081 
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FIG. 3. Antigen-induced  generation of the DFP-sensitive esterase at 0°C. Histamine release 
from samples challenged with antigen at 37°C was  14%. 
and 30 min, washed, and transferred to Tyrode's buffer at 37°C  yielded 50 and 
25 %,  respectively, of the histamine release obtained when antigen challenge 
was carried out in the absence of DFP,  thereby indicating that  considerable 
activation of the esterase had occurred at 0°C.  Replicate  samples  incubated 
with antigen in Tyrode's buffer for 15 and 30 min at 0°C, washed,  and  then 
transferred to DFP-containing buffer at 37°C released 50 and 75 %, respectively, 
of the release obtained from antigen-challenged fragments transferred to buffer 
without DFP; thus, a significant portion of the reaction had progressed beyond 
the I)FP-inhibitable  stage  even at  0°C.  Whereas  the  histamine  release ob- 
served from fragments challenged with antigen in the presence of DFP and 
transferred to a DFP-free buffer reflects residual activatable proesterase, that 
achieved after antigen challenge and transfer of the fragments to DFP-contain- 
ing buffer reflects progression of the biochemical sequence beyond the active 
esterase stage or the capacity of the activated esterase to act upon its natural 
substrate more rapidly than it becomes inactivated by phosphorylation. The 
finding that the sum of the histamine released,  13 and 13.25 %, respectively, 
after 15  or 30 rain of antigen challenge at 0°C,  under the two experimental 
conditions equaled that of tissue challenged directly at 37°C,  14%,  supports 
the concept that the portions of the enzyme in precursor and active forms are 
being assessed. 
Calcium  requirement:  The  development  of  an  experimental  design  that 
permitted an evaluation of the relative proportions of the esterase in precursor 
and active forms led to an analysis of the role of divalent cations in its activa- 
tion  (Fig.  4).  Sensitized  lung  fragments,  incubated  for  10  rain  in  Tyrode's 
buffer containing 1.8 mM calcium and 0.5  mM magnesium, or in buffers de- 
ficient in calcium, magnesium, or both cations, were treated with 5 mM DFP 1082  ANTIGEN-INDUCED RELEASE OF CItEMICAL MEDIATORS 
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[Fio.  4.  Divalent cation requirement for the  antigen-induced generation of the  DFP- 
sensitive esterase. Antigen-induced  histamine release from replicate samples incubated in the 
various buffers but never exposed to DFP was 12.5-15%. 
followed in 10 s by antigen. After an additional 25 min incubation, the antigen- 
challenged fragments were washed and resuspended in fully constituted Tyrode's 
buffer, and the subsequent release of histamine was determined. No release of 
histamine occurred in the presence of DFP regardless of the cation content of 
the buffer. Antigen-challenged fragments treated with DFP in the absence of 
calcium released 9.25  and  10 %  of  their  histamine  after being  washed  and 
transferred  to  Tyrode's buffer, while  replicates  treated  in  the  presence  of 
calcium released only 2.5 and 4 %. Thus, in the absence of extracellular calcium, 
the  antigen-induced  conversion of the serine esterase  to  its active form was 
arrested. The fact that calcium depletion alone did not impair antigen-induced 
histamine release implies that prevention of esterase activation depends upon 
both the absence of extracellular calcium and the inactivation of any active 
esterase by DFP. 
Energy-Requiring Stage.--Antigen challenge of sensitized lung fragments in 
buffer devoid of glucose did not impair mediator release, while the introduction 
of 2-deoxyglucose (2-DG),  a  competitive inhibitor of phosphoglucoisornerase 
(20),  produced  a  dose-dependent inhibition  of the  release  of histamine  and 
SRS-A (2). Inhibition of mediator release by 2-DG required a 3 rain preincuba- 
tion period before antigen challenge (Fig. 5). Reversibility of the inhibition of 
mediator release after antigen challenge in the presence of 2-DG, as assessed 
by washing  and  transfer  of  the  challenged  fragments  to  glucose-containing 
medium, was apparent for less than 3 rain. In order to determine if the antigen- 
induced activation of the DFP-sensitive esterase preceded the labile energy- MICHAEL  KALINER  AND  K.  FRANK  AUSTEN  1083 
requiring  stage,  the  serine  esterase  was maintained  in its  precursor  form by 
combining 2-DG treatment  of sensitized  fragments with antigen  challenge in 
calcium-free buffer containing DFP  (Fig.  6).  Sensitized  lung fragments  were 
incubated in buffer deficient in calcium, magnesium,  and glucose for 5 rain; 5 
mM DFP, 10 mM 2-DG, or both inhibitors were added, followed in 3 min by 
antigen; 1-25 rain later the fragments were removed, washed, and resuspended 
in fully constituted Tyrode's buffer. While the absence of divalent cations and 
glucose from the incubation medium had no effect upon the amount of histamine 
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FIG. 5. Time course of the inhibition  of mediator  release by 2-deoxyglucose. Sensitized 
lung fragments were incubated with 10 mM 2-DG in glucose-free buffer for 0.5-10 rain before 
antigen challenge. (O -I),  histamine released; (O---C)), SRS-A released. Release of hista- 
mine and SRS-A from replicate samples chMlenged in the absence of 2-DG was 20% and 250 
U/g, respectively. 
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FIG. 6. Capacity to prevent the occurrence of the labile energy-requiring stage in mediator 
release by maintaining  the DFP-sensitive  esterase  in its  precursor  state.  Antigen-induced 
histamine release from replicate samples incubated in calcium-, magnesium-, and glucose-free 
buffer in the absence of inhibitors was 22%. 1084  ANTIGEN-INDUCED  RELEASE  OF  CttEMICAL  MEDIATORS 
released from the fragments by antigen challenge, the presence of either DFP or 
2-DG throughout the reaction totally suppressed mediator release. The inhibi- 
tion of the immunologic release of histamine by 2-DG was reversible for only 
1 min after antigen challenge. In contrast, antigen challenge in the presence of 
2-DG plus DFP or DFP alone permitted 15-17 % of the total histamine to be 
released when the fragments were washed and transferred to Tyrode's buffer 
3-25  min later. The finding that DFP treatment of the sensitized  lung frag- 
ments in calcium- and glucose-free buffer prevented the appearance  of the labile 
energy-requiring  step apparent with antigen challenge in the absence of DFP 
indicates that activation of the esterase precedes the energy-requiring  step. 
Second  Calcium-Requiring, EDTA-Inhibitable  Step.--EDTA  produced  a 
dose-related  inhibition of the antigen-induced release of histamine and SRS-A 
(1) with an IDs0 of 0.3 mM and IDl00 of 2 mM having been observed in the 
present experiments.  Although the inhibition by EDTA was reversible if the 
antigen-treated tissue was washed and transferred to fully constituted Tyrode's 
buffer (1), the reversibility was progressively lost beginning 3 min after antigen 
challenge  (Fig.  7).  Suppression  of the immunologic  release  of mediators by 
EDTA occurred immediately after its introduction and, as shown in Table II, 
was reproduced  by magnesium EDTA and reversed  by calcium  and not by 
magnesium. 
Sensitized lung fragments incubated with antigen at 0°C for 30 rain, washed, 
and  transferred to  DFP-containing buffer  gave  full  mediator release  while 
replicate  fragments transferred to calcium-free, EDTA-containing buffer were 
I  0  0  x~ 
~  ~  20 
0  I  I  I  ~_  I  l  I  ~N__ 
I  3  :5  7  9  II  13  15 
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FIG. 7. Time course of the reversibility of EDTA inhibition of the antigen-induced release 
of mediators. Sensitized lung fragments were incubated in calcium- and magnesium-free buffer 
containing 5 mM EDTA for 1 min, challenged with antigen, washed, and transferred to Ty- 
rode's buffer from 1 to 15 min later.  (t  -0),  histamine released; (©---O), SRS-A released. 
Antigen-induced release of histamine and SRS-A from replicate samples in calcium- and mag- 
nesium-free buffer in the absence of EDTA was 49% and 785 U/g, respectively. No antigen- 
induced release of mediators occurred in the presence of EDTA. MICHAEL  KALINER  AND  K.  FRANK  AUSTEN  1085 
markedly inhibited (Table III). Thus, EDTA inhibition of mediator release 
occurs at a  step after the antigen-induced  calcium-dependent activation of the 
serine esterase. 
Attention was next directed towards determining whether this second cap 
TABLE II 
Reversal of EDTA Inhibition of the Immunologix  Rdease of Chemical Mediators 
Divalent cation  Histamine  SRS-Arelease  Antigen challenge in  Wash  content of 2nd  release 
buffer 
%  v/g 
Calcium- and  --  --  11  375 
magnesium-free buffer 
EDTA  --  --  0  0 
EDTA  ~  Mg  ++  0  0 
EDTA  T  Ca  ++  9  375 
MgEDTA  --  --  0  0 
MgEDTA  -I-  Ca  ++  10  375 
Tyrode's buffer  --  --  11  375 
Sensitized human lung fragments were incubated for 1 min in calcium- and magnesium- 
free buffer containing 5 mM EDTA or 5 mM magnesium-EDTA and were challenged with 
antigen.  Replicate samples in EDTA or magnesium-EDTA-containing buffer were washed 
three times in calcium- and magnesium-free buffer 3 min after antigen challenge and trans- 
ferred to buffer containing  calcium or magnesium. 
TABLE III 
Capacity for DFP or EDTA  to Inhibit the Immunologic Release of Histamine after Antigen 
Challenge at O°C 
Second incubation medium  Histamine release 
% 
Tyrode's buffer  27 
5 mM EDTA in calcium- and magnesium-free buffer  6 
5 mM DFP in Tyrode's buffer  20 
Sensitized  human lung fragments  were challenged  with antigen in Tyrode's buffer at 
0°C, incubated at 0°C for 30 min, washed, and transferred  to a second incubation medium 
at 37°C. No antigen-induced mediator release occurred at 0°C. Replicate samples challenged 
by antigen in Tyrode's buffer at 37°C released 27% of their total histamine content. 
cium-requiring,  EDTA-inhibitable step  preceded  or  followed  the  energy- 
dependent phase  (Fig. 8).  Sensitized lung fragments were incubated in buffer 
deficient in divalent cations and  containing EDTA  (5  mM)  or  deficient in 
glucose and  containing 2-DG  (10  raM)  for  3  min, challenged with  antigen, 
washed  3  min  later,  and  resuspended  in  fully  constituted Tyrode's  buffer. 
Replicate samples in  EDTA-containing buffer were  transferred  1  min after 
antigen challenge to  buffer devoid of  calcium, magnesium, and glucose and 1086  ANTIGEN-INDUCED  RELEASE  OF  CHEMICAL MEDIATORS 
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Flo. 8. Failure of 2-deoxyglucose to prevent cation reversal of EDTA inhibition of media- 
tor release. Antigen-induced  histamine  and SRS-A release from replicate  samples incubated 
in  either  calcium- and  magnesium-free or  glucose-free  buffer was  23-24%  and  750  U/g, 
respectively, in both instances. 
containing both EDTA and 2-DG;  one-half the samples were maintained  in 
this buffer while the others were transferred 3 rain later to glucose-free buffer 
containing 2-DG  in the presence  of calcium and magnesium.  Sensitized lung 
fragments challenged with antigen in the presence of EDTA or 2-DG  released 
no  mediators,  but  after being  washed  and  transferred to  normal  Tyrode's 
buffer yielded approximately 80 and 60 %, respectively,  of the histamine and 
SRS-A released  from replicate  fragments challenged  with antigen but never 
exposed  to  either  inhibitor.  Transfer  of  antigen-challenged  lung  fragments 
from buffer  containing EDTA  to  buffer  containing both  EDTA  and  2-DG 
yielded no  mediator  release;  in  contrast,  subsequent  transfer  of  replicate 
fragments to buffer  containing 2-DG  was  accompanied  by mediator release 
comparable  to  that observed  from fragments challenged  in  the presence  of 
EDTA and transferred directly to fully constituted Tyrode's buffer. The failure 
of 2-DG  to prevent  cation reversal  of EDTA  inhibition indicates that  the 
energy-requiring  stage cannot follow the calcium-requiring,  EDTA-inhibitable 
step. 
EDTA  should  therefore  be  capable  of preventing mediator release  after 
glucose reversal  of 2-DG  inhibition  (Fig.  9).  Sensitized  lung fragments, in- 
cubated in buffer devoid of divalent cations and containing EDTA or deficient 
in  glucose  and  containing 2-DG  for 3  rain,  were  challenged  with  antigen, 
incubated  for  3  rain,  washed,  and  transferred  to  normal  Tyrode's  buffer. 
Replicate samples in 2-DG were transferred 3 rain after antigen challenge to 
calcium-  and  magnesium-free  buffer  containing EDTA;  half the  fragments MICHAEL  IC&LINER  AND  K.  FRANK  AUSTEN  1087 
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FIo. 9.  Capacity of EDTA to prevent glucose reversal of 2-deoxyglucose  inhibition of 
mediator release. Antigen-induced histamine and SRS-A release in calcium- and magnesium- 
free or glucose-free  buffer was 18% and 500 U/g, respectively. 
were maintained  in  this buffer while  the  other half were  transferred 3  min 
later  to  fully constituted Tyrode's buffer. Lung  tissue  replicates challenged 
with  antigen in the presence of EDTA or 2-DG released no mediators,  but 
upon transfer to normal buffer yielded 85 and 90%, respectively, of the hista- 
mine  and  SRS-A  released  by  replicates  challenged  with  antigen  but  never 
exposed to either inhibitor. Transfer of antigen-treated lung fragments from 
2-DG-containing buffer to EDTA-containing medium maintained  the inhibi- 
tion of mediator release despite the absence of 2-DG and presence of glucose, 
while replicate samples  transferred to divalent cation-containing buffer were 
reconstituted in terms of mediator release. Thus,  the  energy-requiring stage 
must  precede  the  second  calcium-requiring,  EDTA-inhibitable  step  in  the 
antigen-induced reaction. 
Cyclic A MP-Inhibitable Stage.--In order to determine the site at which cyclic 
AMP modulates the immunologic release of chemical mediators, it was neces- 
sary to investigate the effects on cyclic AMP levels of the various maneuvers 
employed to develop the sequence. As shown in Table IV, stimulation of frag- 
ments in Tyrode's buffer by 1/~M isoproterenol increased the tissue concentra- 
tions of cyclic AMP from 6.4 pmol/Ing protein nitrogen (pmol/mg prot N) to 
223 pmol/mg prot N, and the results in calcium- and magnesium-free buffer, 
glucose-free buffer  containing  2-DG,  and  Tyrode's  buffer  containing  DFP 
were  comparable.  EDTA  in  calcium-  and  magnesium-free  buffer increased 
baseline cyclic AMP to 41 pmol/mg prot N  and exhibited a synergistic effect 
when combined with  isoproterenol, the  tissue  level of cyclic AMP  rising  to 
520 pmol/mg prot N. 1088  ANTIGEN-INDUCED  RELEASE  OF  CHEMICAL  MEDIATORS 
As EDTA alone increased  cyclic AMP concentrations  and acted synergisti- 
cally with isoproterenol,  the capacity of isoproterenol to prevent calcium reversal 
of EDTA inhibition of the immunologic  release  of mediators was determined 
(Fig.  10).  Sensitized  lung fragments suspended in  calcium-  and  magnesium- 
TABLE  IV 
Effect of Various Inhibitors of Mediator Rdease upon the Capacity of Isoproterenol to Increase 
the Intracdlular Lerds of Cyclic AMP 
Agent  Isoproterenol  Cyclic AMP 
pmol/rng prot N  (SEM) 
Tyrode's buffer  --  6.4  (2.3) 
....  Jr  223.0  (18.6) 
Calcium- and magnesium-free buffer  --  6.3  (1.8) 
........  +  248.6  (26.0) 
EDTA  --  41.2  (3.4) 
"  q-  520.2  (28.9) 
2-DG  --  6.5  (2.1) 
"  +  193.7  (16.4) 
DFP  --  10.2  (I  .6) 
"  q-  207.6  (14.3) 
The cyclic AMP content of human lung  fragments was determined after a  5 min incuba- 
tion at 37°C in Tyrode's  buffer, calcium- and magnesium-free buffer, calcium- and magne- 
sium-free buffer  containing 5  mM  EDTA,  glucose-free buffer containing 10  mM  2-DG,  or 
Tyrode's buffer containing  5 mM DFP. Replicate samples were incubated in these same buf- 
fers containing 1 #M isoproterenol. 
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FIG.  10. Capacity of isoproterenol to prevent cation reversal of EDTA inhibition of media- 
tor release.  Antigen-induced histamine and  SRS-A release in calcium- and  magnesium-free 
buffer in  the  absence of  EDTA  was  16%  and  150  U/g,  respectively.  No  antigen-induced 
release of mediators  occurred in  the presence of either  EDTA  or isoproterenol. MICHAEL  KALINER  AND  K.  PRANK  AUSTEN  1089 
free buffer containing 5mM EDTA were challenged  with antigen,  incubated 
for 3 min, washed, and transferred to Tyrode's buffer, either alone or containing 
0.5 #M isoproterenol.  Samples  transferred to isoproterenol  yielded less than 
40% of the release of mediators obtained from fragments transferred to buffer 
alone. In order to eliminate the effects of EDTA on the tissue levels of cyclic 
AMP, another set of replicate  samples was washed 3 min after antigen chal- 
lenge in the presence  of EDTA, transferred to calcium- and magnesium-free 
Tyrode's buffer for an additional 5 min, and then placed in Tyrode's buffer 
with and without isoproterenol.  Isoproterenol  again prevented cation reversal 
of  the  EDTA-dependent inhibition, placing  the  inhibitory action of  cyclic 
AMP coincident with or subsequent to the second calcium-requiring,  EDTA- 
inhibitable step.  These data were supported by the demonstration that sen- 
sitized  tissue  challenged  by antigen in glucose-free buffer  containing 2-DG, 
washed, and transferred to normal Tyrode's buffer released histamine and SRS- 
A, while replicate samples transferred to buffer containing 5 ~M isoproterenol 
did not. 
DISCIJSSION 
Five sequential steps interspaced  between the antigen-induced  activation of 
human lung fragments sensitized with IgE and the release of chemical mediators 
have  been  delineated.  The  experimental  design  (Fig.  1)  that  permits  this 
analysis is based upon the capacity to maintain the serine esterase  essential 
to mediator release in its DFP-resistant precursor  state despite  antigen chal- 
lenge and upon the ability to arrest reversibly the reaction sequence by various 
manipulations.  The  former  permitted  determination  of  those  conditions 
essential  to  activation of  the  serine  esterase.  The  latter permitted various 
inhibitory maneuvers to be sequenced; reversal of the initial arresting condition 
with restoration of mediator release in the presence  of a  second inhibitor of 
different character indicated that the new agent exerted  its inhibitory effect 
before the step at which the reaction had been arrested,  while continued in- 
hibition indicated that the new condition acted subsequently. 
As the DFP-sensitive serine esterase involved in histamine release exists in 
a DFP-resistant precursor  form (Table I, exp. A), the capacity for lung tissue 
fragments, challenged with antigen in the presence of DFP, to release histamine 
after being  washed  reflects  residual  proesterase  activatable by tissue-bound 
antigen.  Varying the  time interval between  immunologic  activation in  the 
presence of DFP and transfer of the lung fragments to Tyrode's buffer reveals 
progressive  depletion  of the residual  activatable proesterase  at 37°C (Fig. 2) 
and even at 0°C (Fig. 3). That this depletion  at 0°C is due to the formation 
of the active esterase in the presence of DFP is revealed by parallel  studies in 
which DFP, introduced 15 and 30 min after antigen challenge at 0°C, permits 
the release of histamine either because the reaction has progressed beyond the 
esterase or because the active esterase has a greater reactivity with its natural 1090  ANTIGEN-INDUCED  RELEASE  OF  CHEMICAL  MEDIATORS 
substrate than with the phosphorylating agent. The finding that the sum of the 
histamine released by the residual activatable esterase,  after transfer of the 
tissue  challenged  with  antigen  in  the presence  of DFP,  and  by  the  active 
esterase, after transfer of tissue challenged with antigen to buffer containing 
DFP, is identical to the amount released from tissue directly challenged in the 
absence of DFP supports the view that these two maneuvers assess  the total 
tissue content of the precursor and active esterase (Fig. 3). 
Whereas antigen  challenge of sensitized tissue in  the presence of DFP at 
both 37  ° and 0°C  (Figs.  2 and 3)  permitted depletion of the proesterase by 
activation to its esterase form, this was not the case when calcium was omitted 
from  the  DFP-containing  buffer  (Fig.  4).  Sensitized  lung  tissue  fragments 
challenged at 37°C in calcium-free buffer containing DFP released no histamine 
until washed and transferred to Tyrode's buffer; full histamine release was then 
observed (Fig. 4), indicating preservation of the proesterase state of the enzyme 
until transfer. Since calcium depletion alone does not prevent antigen-induced 
histamine release at 37°C  (Table II),  the inability of antigen to activate the 
proesterase depends  upon both  the absence of extracellular calcium and  the 
presence of DFP. The full mediator release by antigen challenge in the absence 
of extracellular calcium, in contradistinction to maintenance of the proesterase 
state when DFP is present in calcium-free buffer, indicates a minimal calcium 
requirement for initial antigen-induced activation of the proesterase followed 
by autocatalytic activation by the activated esterase. 
Both EDTA and DFP  inhibited  the reaction when added simultaneously 
with antigen,  while 2-DG required a  3 min period of preincubation with the 
tissue  in  glucose-free buffer in order to suppress  the  immunologic release of 
mediators (Fig. 5). Further, the antigen-activated stage blocked by the presence 
of 2-DG was labile and could be reversed, as assessed by subsequent mediator 
release, only if the tissue was washed and restored to normal buffer within 1-3 
rain  of antigen challenge  (Fig.  6).  The capacity of the combination of DFP 
and depletion of calcium to prevent activation of the serine esterase (Fig. 4) 
should  preclude  the  reaction from reaching  the  2-DG-inhibitable  but  labile 
step if the esterase activation occurs earlier than the energy step in the reaction 
sequence, and this indeed was the case (Fig. 6). 
EDTA  could  inhibit  mediator  release  either  by  preventing  the  calcium- 
dependent activation of the proesterase or by acting at an additional divalent 
cation-requiring step. The divalent cation requirement for both esterase activa- 
tion (Fig. 4) and reversal of EDTA inhibition (Table II) is met by calcium and 
not by magnesium. Reversibility of the inhibition of mediator release by EDTA 
is  accomplished  completely by washing  the  tissue  and  replenishing  calcium 
within 3 min after antigen challenge; it falls off entirely over the next 12 rain 
(Fig.  7).  The finding  that  the  antigen-induced reaction sequence progresses 
over 30 min at 0°C to a point where transfer of the tissue to DFP-containing 
buffer permits mediator release (Fig. 3, Table III), while transfer to EDTA- MICHAEL  KALINER  AND  K.  FRANK  AUSTEN  1091 
containing buffer does not  (Table III), places the second calcium-requiring, 
EDTA-inhibitable step subsequent to the appearance of the activated esterase. 
That it is also subsequent to  the energy-requiring, 2-DG-inhibitable step is 
indicated by the inhibition of mediator release by EDTA after glucose reversal 
of 2-DG inhibition (Fig. 9). Conversely, the finding that 2-DG does not prevent 
calcium reversal of EDTA inhibition established that the energy step precedes 
this second calcium-requiring, EDTA-inhibitable stage (Fig. 8). 
The finding that isoproterenol prevents calcium reversal of EDTA inhibition 
of mediator release could mean that increased concentrations of cyclic AMP 
act  either  coincident with  or  subsequent  to  the  second  calcium-requiring, 
EDTA-inhibitable step (Fig. 10). A coincident site of action might be in terms 
of  the  synergistic effect of EDTA  and  isoproterenol  on  cyclic AMP  levels 
(Table IV), an action possibly related to the inhibitory effect of calcium on 
adenylate  cyclase  (21).  The  capacity  of  isoproterenol  to  inhibit  mediator 
release after the tissue has been transferred from EDTA-containing buffer to 
calcium-  and  magnesium-free buffer,  a  maneuver designed to  eliminate the 
synergism between isoproterenol  and  EDTA,  favors discrete  sites  of action 
(Fig. 10). Further, the immediate reversibility of EDTA inhibition by calcium 
as opposed to the persistent inhibition by isoproterenol as assessed by washing 
and transferring the fragments to Tyrode's buffer from I to 15 min after'antigen 
challenge again favors individual sites of action. An attractive possibility would 
be a role for intracellular calcium in the activation of a contractile protein that 
is inhibited through phosphorylation by a  cyclic AMP-dependent kinase. 
It was not possible to study the site at which 8-bromo cyclic 3', 5'-guanosine 
monophosphate  (8-bromo  cyclic  GMP)  acts  to  enhance  the  immunologic 
release of chemical mediators (4) as the experimental design used to sequence 
the reactions relies  on calcium depletion at two discrete stages, and the aug- 
mentation of mediator release by 8-bromo cyclic GMP is not observed in the 
absence of extracellular calcium. 
The sequence of biochemical events initiated by the interaction of ragweed 
antigen with  tissue-fixed antiragweed  IgE  antibodies  in  human  lung  tissue 
(Fig. 11) proceeds from the calcium-dependent activation of a DFP-sensitive 
serine esterase; the further autocatalytic activation of the esterase; a  2-DG- 
inhibitable energy requirement; a second calcium-requiring, EDTA-inhibitable 
stage; and a cyclic AMP-suppressible step to the release of histamine and SRS-A. 
Although the scheme depicts SRS-A release as involving activation of a DFP- 
sensitive esterase, as has been firmly established for histamine, this point in 
fact could not be studied due to the inhibition of SRS-A release by preincuba- 
tion with DFP before antigen challenge (Table I, exp. B). Three of these steps 
have also been recognized in the  release  of histamine from the isolated rat 
peritoneal mast cell treated with band 2 protein derived from rabbit leukocytes 
(22). Histamine release induced by this cationic protein involves the activation 
of a DFP-sensitive esterase from a DFP-resistant precursor form, an energy- 1092  ANTIGEN-INDUCED RELEASE  OF  CHEMICAL  MEDIATORS 
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Fia.  11. Schematic diagram of the sequence of biochemical  events in the antigen-induced 
release of chemical  mediators from human lung tissue sensitized with IgE. 
requiring step inhibitable by dinitrophenol or iodoacetate in glucose-free me- 
dium, and an EDTA-inhibitable stage recognized only by initiating the reaction 
at 0°C and then transferring the cells to 37°C buffer with EDTA. A calcium 
requirement was  not  established for either esterase activation or reversal of 
EDTA inhibition. The division of antigen-induced histamine release from mixed 
cell populations of human  leukocytes into a  calcium-independent activation 
stage and a  calcium-dependent release phase  (15)  has been accompanied by 
evidence that inhibition by isoproterenol and 2-D G occur in the initial and final 
phases,  respectively  (23).  Such  a  sequence  might  be  explicable  if  calcium 
deficiency alone prevented esterase activation in this system and in addition 
had  a  synergistic effect with  isoproterenol. 
SUMMARY 
Five sequential steps interspaced between the antigen activation of human 
lung fragments sensitized with IgE and the release of the chemical mediators, 
histamine  and  slow-reacting  substance  of  anaphylaxis  (SRS-A),  have  been 
delineated. The experimental design that permits this analysis is based upon 
the capacity to maintain the serine esterase essential to mediator release in its 
diisopropylphosphofluoridate (DFP)-resistant precursor state despite antigen 
challenge and upon the ability to arrest reversibly the reaction sequence by 
various manipulations.  When  sensitized lung fragments are  challenged with 
antigen in the presence of DFP, a serine esterase is converted to its active DFP- 
inhibitable  state;  this  conversion  is  prevented  if  antigen  challenge  in  the 
presence  of DFP  occurs in  calcium-free buffer indicating  that  immunologic 
activation of the esterase requires extracellular calcium. The fact that calcium 
depletion  alone  does  not  impair  antigen-induced  histamine  release  implies 
that  prevention  of  esterase  activation  depends  upon  both  the  absence  of 
extracellular calcium and the inactivation of any active esterase by DFP to 
prevent an autocatalytic  feedback activation.  Arresting  the  antigen-induced 
activation of the serine esterase by the combination of DFP in calcium-free 
buffer precludes the sequence from reaching the labile, 2-deoxyglucose (2-DG)- MICHAEL  KALINER  AND  K.  FRANK  AUSTEN  1093 
inhibitable,  energy-requiring  step,  indicating  that  proesterase  activation 
precedes  this  energy-requiring  stage.  The  2-DG-inhibitable  step  precedes  a 
second calcium-requiring, EDTA-inhibitable stage, as EDTA prevents glucose 
reversal of 2-DG inhibition of antigen-challenged tissue, while the presence of 
2-DG does not prevent calcium reversal of EDTA inhibition. The finding that 
isoproterenol prevents calcium reversal of EDTA inhibition of mediator release 
suggests that the inhibitory site of action of increased concentrations of cyclic 
AMP is coincident with or subsequent to the second calcium-requiring, EDTA- 
inhibitable step. Therefore, the sequence of biochemical events initiated by the 
interaction of antigen with tissue-fixed IgE antibodies appears to proceed from 
the calcium-requiring activation of a DFP-sensitive serine esterase; the further 
autocatalytic  activation  of  the  esterase;  a  2-DG-inhibitable  energy  require- 
ment; a second calcium-requiring, EDTA-inhibitable stage; and a cyclic AMP- 
inhibitable step to the release of histamine and SRS-A. 
The authors gratefully acknowledge the skilled technical assistance of Ms. Nancy Tim- 
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